Please assess the completion status of the following clinical trial:

Trial Title: Side Effects of 4 Times Bone Marrow Mono Nuclear Transplantation in Patients With Ischemic Lower Limb

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ischemic lower limb based on TASK guide line~* Rutherford score:2,3~* ABI\<0.6~* Absolute ankle pressure \< 60 mmHg~* Both gender~* Age:20-62years~Exclusion Criteria:~* EF\<30%~* Cr\>2~* HbA1c\>8%~* Bone marrow disorders:leukemia~* Cognitive disorders~* Infections~* MI with ST elevation during last month~* Malignancy~* Immunologic or rheumatologic disorders

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 62 Years
- Healthy Volunteers: f

Study Arms:
- 4times injection (Type: EXPERIMENTAL): the patients with ischemic lower limb ulcer who underwent 4times stem cell injection.
- one injection (Type: EXPERIMENTAL): Patients with peripheral artery disease underwent cell transplantation just one time.

Based on this trial design, predict the completion outcome and termination type (if applicable).